MedPath

PMS-PALBOCICLIB

PMS-PALBOCICLIB

Approved
DIN Number

02552140

Drug Class

Human

Market Date

Sep 27, 2024

Company
HC

Pharmascience Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02552140
AIG Number0157970003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01EF01 PALBOCICLIB
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

PALBOCICLIBActive
Strength: 125 MG
Monograph: PALBOCICLIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.